| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/20/2006 | CN1833669A Plant volatile oil having broad spectrum antibiotic activity, its prepn. method and usage |
| 09/20/2006 | CN1833667A Natural indigo ketone oral liquor or injection and usage |
| 09/20/2006 | CN1833662A Medicine for treating tuberculosis |
| 09/20/2006 | CN1833654A Composition of figwortfower picrorhiza rhizome iridoid total glucoside and nucleoside medicine for treating virus hepatitis |
| 09/20/2006 | CN1833644A Abrotine, its derivative dihydro-abrotine, artemether, arteether and arte sunate in use of pharmacy |
| 09/20/2006 | CN1833643A Entikawei solid dispersion compsns. and prepn. thereof |
| 09/20/2006 | CN1276086C A double-stranded DNA molecule and its use in preparing medicine for inhibiting hepatitis B virus replication |
| 09/20/2006 | CN1276083C Altering gene expression with ssDNA produced in vivo |
| 09/20/2006 | CN1276079C Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 09/20/2006 | CN1275970C Novel carbapenem derivatives |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275961C Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275947C Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof |
| 09/20/2006 | CN1275650C Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof |
| 09/20/2006 | CN1275649C Bivalence polypeptide vaccine for resisting A type and O type foot-and-mouth disease virus and its preparation |
| 09/20/2006 | CN1275648C Vaccin composition, preparation method and use thereof |
| 09/20/2006 | CN1275646C Nose drops of recombined human interferon alpha 2b and preparing method |
| 09/20/2006 | CN1275644C Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication |
| 09/20/2006 | CN1275640C Medicine for treating chromic avidity, persistent hepatitis B and its preparation method |
| 09/20/2006 | CN1275629C Cinese traditional medicine for treating infectant virosis and preparation method |
| 09/20/2006 | CN1275621C Extract product of Chinese traditional medicine as well as preparation method and application |
| 09/20/2006 | CN1275617C Externally applied agent for relieving inflammation and antibiosis |
| 09/20/2006 | CN1275613C Medicinal composition for treating tuberculosis and its preparing process |
| 09/20/2006 | CN1275611C External remedy for treating Hang Kong foot |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275603C Oral compositions for hiv-infected subjects |
| 09/20/2006 | CN1275601C Composition and method of tissue superoxygenation |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 09/19/2006 | US7109209 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109190 Carbacephem β-lactam antibiotics |
| 09/19/2006 | US7109183 Phosphohalohydrins, process for the production thereof and use thereof |
| 09/19/2006 | US7109182 Synthetic oligomannosides, preparation and uses thereof |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109172 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/19/2006 | US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 09/19/2006 | US7109025 Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
| 09/19/2006 | US7108981 Administering monoclonal antibody that specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), wherein the monoclonal antibody is produced by a hybridoma in a pharmaceutically acceptable carrier for therapy of Kaposi's sarcoma-associated herpesvirus infection |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/19/2006 | US7108865 Controlled-release dosage forms of azithromycin |
| 09/19/2006 | US7108861 Environmentally benign crop protection agents |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/14/2006 | WO2006095624A1 Protease inhibitor |
| 09/14/2006 | WO2006095542A1 Pharmaceutical composition comprising amine compound |
| 09/14/2006 | WO2006095180A2 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars |
| 09/14/2006 | WO2006095178A1 Medicament and treatment for herpes simplex |
| 09/14/2006 | WO2006094930A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 09/14/2006 | WO2006094828A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 09/14/2006 | WO2006094756A2 Varicella zoster virus vaccine |
| 09/14/2006 | WO2006094662A1 New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal |
| 09/14/2006 | WO2006094347A1 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 09/14/2006 | WO2006094327A1 Pharmaceutical preparation for treating mycobacterial infections |
| 09/14/2006 | WO2006077427A3 Antiviral drug combinations |
| 09/14/2006 | WO2006077139A3 Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same |
| 09/14/2006 | WO2006043153A3 Use of zinc and copper chelators for the treatment of viral diseases |
| 09/14/2006 | WO2006034337A3 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 09/14/2006 | WO2006011792A3 Antimicrobial peptides derived from cap18 |
| 09/14/2006 | US20060205769 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205646 Methods for increasing cell and tissue viability |
| 09/14/2006 | US20060205640 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 09/14/2006 | US20060205049 Method for the production of resveratrol in cell cultures |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204594 Inhibition of enzyme activity by adsorptive removal of controlling ions |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204579 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal |
| 09/14/2006 | US20060204543 Semirigid implant of glycolic acid-lactic acid copolymer with hydroxypropylmethyl cellulose as release modifier for cyclosporine; biodegradation; sustained release |
| 09/14/2006 | US20060204523 Flavivirus vaccine delivery system |
| 09/14/2006 | US20060204520 Vaccine composition |
| 09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | CA2600905A1 Varicella zoster virus vaccine |
| 09/14/2006 | CA2600886A1 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 09/14/2006 | CA2597213A1 Compositions and methods for treating or preventing flaviviridae infections |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700600A1 Fulvic acid and its use in the treatment of inflammation |
| 09/13/2006 | EP1700599A1 Fulvic acid and its use in the treatment of candida infections |
| 09/13/2006 | EP1699808A1 Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| 09/13/2006 | EP1699806A1 Glycosaminoglycan (gag) mimetics |